ALNYLAM PHARMACEUTICALS INVESTOR REMINDER: Hagens Berman Reminds Investors in Alnylam Pharmaceuticals, Inc. of the Firm’s Investigation into Possible Securities Law Violations
October 25, 2016 09:30 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Oct. 25, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in Alnylam Pharmaceuticals, Inc. that the firm is investigating possible securities law...
ALNYLAM PHARMACEUTICALS INVESTOR ALERT: Hagens Berman is Investigating Possible Securities Law Violations by Alnylam Pharmaceuticals, Inc. and Officers
October 06, 2016 18:04 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Oct. 06, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in Alnylam Pharmaceuticals, Inc. that the firm is investigating possible securities law violations...